ARTICLES BY THIS AUTHOR
- 6/9/2021
Moderna seeks clearance for COVID-19 vaccine to be used in adolescents
Moderna's submission is based on a Phase 2/3 study of mRNA-1273 in adolescents age 12 years old to less than age 18 years old in the United States. - 6/9/2021
FDA approves Novo Nordisk's Wegovy
Wegovy, an under-the-skin injection, is the first approved drug for chronic weight management in adults with general obesity or overweight. - 6/8/2021
NCPA opens registration for in-person 2021 annual convention
The event is scheduled to take place on Oct. 9 to 12 in Charlotte, N.C. - 6/8/2021
NACDS op-ed reinforces pharmacies’ continued role in COVID-19 vaccinations
NACDS chair Colleen Lindholz and vice chair Brian Nightengale emphasized pharmacies’ continued role in fostering vaccine confidence and ensuring equitable access to COVID-19 vaccines. - 6/8/2021
CVS Health completes rollout of time-delay safes in Georgia pharmacies
All 355 CVS Pharmacy locations in Georgia are now using time-delay safe technology. - 6/8/2021
Hy-Vee to enhance digital capabilities via Google Cloud partnership
Hy-Vee is using Google Cloud services to make online shopping easier for e-commerce shoppers, integrate its virtual dietitian services and enable customers to schedule vaccinations online. - 6/8/2021
CVS Health opens MinuteClinic locations in Utah
CVS Health has opened six MinuteClinic locations in Utah. - 6/8/2021
FDA approves Pfizer’s Prevnar 20 vaccine
Prevnar 20 is a vaccine to prevent invasive disease and pneumonia caused by 20 serotypes of pneumococcus. - 6/8/2021
Patrick Genestin to lead Hikma's generics business development
Genestin previously served as vice president of business development and licensing, and mergers and acquisitions for the U.S. entity of Sandoz.